Oncolytic Virotherapy as an Immunotherapeutic Strategy for Multiple Myeloma

Blood Cancer Journal - United States
doi 10.1038/s41408-017-0020-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Oncolytic Virotherapy for Multiple Myeloma Using a Tumour-Specific Double-Deleted Vaccinia Virus

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Oncolytic Virotherapy

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Oncolytic Virotherapy for Human Malignant Mesothelioma: Recent Advances

Oncolytic Virotherapy
2015English

Delivery and Biosafety of Oncolytic Virotherapy

Frontiers in Oncology
Cancer ResearchOncology
2020English

Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress

Current Pharmaceutical Biotechnology
BiotechnologyPharmaceutical Science
2012English

Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy

Cancer immunology research
Cancer ResearchImmunology
2018English

Targeting Pediatric Cancer Stem Cells With Oncolytic Virotherapy

Pediatric Research
Child HealthPediatricsPerinatology
2012English

Progress in Oncolytic Virotherapy for Treatment of Thyroid Malignant Neoplasm

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Overcoming the Limitations of Locally Administered Oncolytic Virotherapy

BMC Biomedical Engineering
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy